SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

Stock Information for SiNtx Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About SiNtx Technologies Inc.

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms
SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4-5
SINTX Technologies to Participate in Sidoti & Company Investor Conference
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride-PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants
SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies
SINTX Technologies Announces Launch of OsseoSculpt(TM) an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System
UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.